SCHEMBL19851498

SCHEMBL19851498

CC(C)(C)OC(=O)NCCCC[C@H](NCc1ccc2ccccc2c1)C(=O)NCCC1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 2/20 0.51
▸ MC1R Q01726 2/20 0.51
▸ MC3R P41968 1/20 0.51
▸ BCHE P06276 2/20 0.48
▸ CTSB P07858 1/20 0.45
▸ CTSS P25774 1/20 0.45
▸ CTSK P43235 1/20 0.45
▸ METAP2 P50579 1/20 0.44
▸ METAP1 P53582 1/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ NMT2 O60551 5/20 0.43
▸ NMT1 P30419 5/20 0.43
▸ PSMB1 P20618 1/20 0.41
▸ PSMB8 P28062 1/20 0.41
▸ PSMB9 P28065 1/20 0.41
▸ PSMB5 P28074 1/20 0.41
▸ TLR2 O60603 1/20 0.41
▸ ACACB O00763 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19839628 0.88 MC4R (0.55) MC4RMC1RMC3RBCHEMETAP2
SCHEMBL19839630 0.88 MC4R (0.55) MC4RMC1RMC3RBCHEMETAP2
SCHEMBL19839703 0.85 NMT1 (0.57) MC4RMC1RMC3RBCHEMETAP2
SCHEMBL19839702 0.85 NMT1 (0.57) MC4RMC1RMC3RBCHEMETAP2
SCHEMBL19851733 0.85 MC4R (0.53) MC4RMC1RMC3RCTSBCTSS
SCHEMBL19839742 0.85 MC4R (0.52) MC4RMC1RMC3RCTSBCTSS
SCHEMBL19839739 0.85 MC4R (0.52) MC4RMC1RMC3RCTSBCTSS
Hydrochloric Acid SCHEMBL19839690 0.84 NMT1 (0.56) MC4RMC1RMC3RBCHEMETAP2
Hydrochloric Acid SCHEMBL19839689 0.84 NMT1 (0.56) MC4RMC1RMC3RBCHEMETAP2
SCHEMBL28291231 0.84 MC4R (0.57) MC4RMC1RMC3RBCHECTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026866-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION NEUROPORE THERAPIES, INC. (US) 2018-02-08 — — WO disclosed
Send feedback